Abstract
The purpose of this chapter is to focus the attention of cardiac electrophysiologists on the importance of psychiatric disorders in patients with cardiac disease and identify major gaps in our knowledge on the diagnosis and treatment of affective disorders in patients with a history of life-threatening arrhythmias. First, the chapter provides a background on the significance of mental disorders and their possible relations to cardiovascular disease. Second, it reviews the world literature on mood, anxiety, and cognitive disorders in ICD recipients. Third, it addresses the treatment of depression and anxiety, psychiatric disorders most frequently affecting ICD patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Diagnostic and Statistical Manual of Mental Disorders (DSM IV). Fourth Edition. American Psychiatric Association, Washington D.C., 1994.
Cross-National Collaborative Group (CNCG). The changing rate of major depression-Cross-national comparisons. JAMA 1992;268:3098–30105
Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 1994;151:979–986
Steffens DC, Skoog I, Norton MC, Hart AD, Tshanz JT, Plassman BL, Wyse BW, Welsh-Bohmer KA, Breitner JC. Prevalence of depression and its treatment in an elderly population: the Cache County Study. Arch Gen Psychiatry 2000;57:601–60
Doris A, Ebmeier K, Shajahan P. Depressive ilness. Lancet 1999; 354:1369–1375
Wiessman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen H-U. Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993;29:77–84
Mendlowicz MV, Stein MB. Quality of life with anxiety disorders. Am J Psychiatry 2000;157:669–682
Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Goldberg D, Magruder KM, Schulberg HC, Tylee A, Wittchen H-U. Consensus statement of the primary care management of depression from the International Group on Depression and Anxiety. J Clin Psychiatry 1999;60(suppl 7):54–61
Lenze EJ, Mulsant BH, Shear MK, Schulberg HC, Dew MA, Begley AE, Pollock BJ, Reynolds CF 3rd. Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 2000;157:722–728
Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990;51 (suppl 6):3–11
Fifer SK, Mathias SD, Patrick DL, Mazonson PD, Lubeck DP, Buesching DP. Untreated Anxiety among adult primary care patients in health maintenance organization. Arch Gen Psychiatry 1994;51:740–750
Druss BG, Hoff RA, Rosenheck RA. Underduse of antidepressants in major depression: prevalence and correlates in a national sample of young adults. J Clin Psychiatry 2000; 61:234–237
Nemeroff CB, Musselman DL, Evans DL. Depression and cardiac disease. Depress Anxiety 1998;8 (suppl 1):71–79
Greenberg PE, Stiglin LE, Finkelstein SN, Berndt RE. Depression: a neglected major illness. J Clin Psychiatry 1993;54:419–424
Steffens DC, Hays JC, Krishnan KR. Disability in geriatric depression. Am J Geriatr Psychiatry 1999;7:34–40
Steffens DC, O’Connor CM, Jiang WJ, Pieper CF, Kuchibhatla MN, Arias RM, Look A, Davenport C, Gonzales MB, Krishnan KR. The effect of major depression on functional status in patients with coronary artery disease. J Am Geriatr Soc 1999;47:319–322
Unutzer J, Patrick DL, Simon J, Grembowski D, Walker E, Rutter C, Katon W. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 1997;277:1618–1623
Rosenman RH, Brand RJ, Sholtz RJ, Jenkins CD, Friedman M, Strauss R, Wurm M. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8’/z years. JAMA 1975;233:872–877
Coronary-prone behavior and coronary heart disease: a critical review. XXX,Circulation 1981;63:1199–1215
Ragland DR, Brand RJ. Type A behavior and mortality from coronary heart disease. New Engl J Med 1988;318:65–69
Case RB, Heller SS, Case NB, Moss AJ, and the Multicenter Post-Infarction Research Group. Type A behavior and survival after acute myocardial infarction. New Engl J Med 1985;312:737–741
Ahem DK, Gorkin L, Anderson JL, Tierney C, Hallstrom A, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA, Richardson DW, Follick MJ, and the CAPS Investigators. Behavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmias Pilot Study (CAPS). Am J Cardiol 1990;66:59–62
Iribarren C, Sidney S, Bild DE, Liu K, Markovitz JH, Roseman JM, Matthews K. Association of hostility with coronary artery calcification in younger adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults. JAMA 2000;283:2546–2551
Scherwitz LW, Perkins LL, Chesney MA, Hughes GH, Sidney S. Hostility and health in young adults: the CARDIA Study. Coronary Risk Developmenmt in Young Adults Study. Am J Epidemiol 1992;136–145
Stoney CM, Engebretson TO. Plama homocysteine concentrations are positively associated with hostility and anger. Life Sci 2000;66:2267–2275
Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627–633
Freedland KE, Carney RM, Lustman PJ, Rich MW, Jaffe AS. Major depression in coronary artery disease patients with or without a prior history of depression. Psychosom Med 1992;54:416–421
Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Circulation 1996;94:31233129
Silverstone PH. Depression and outcome in acute myocardial infarction. Brit Med J (Clin Res Ed)1987;294:219–220
Scleifer SJ, Macari-Hinton MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD. The nature and course of depression following myocardial infarction. Ann Intern Med 1989;149:1785–1789
Ladwig KH, Kieser M, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J 1991;12:959–964
Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction--Impact on 6-month survival. JAMA 1993;270:1819–1825
Orth-Gomer K, Edwards ME, Erhardt L, Sjogren A, Theorell T. Relation between arrhythmias and psychological profile. Acta Med Scand 1980;207:31–36
Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O’Conner C, Stone PH, Freedland KE. Depression, heart rate variablitiy, and acute myocardial infarction. Circulation 2001;104:2024–2028
Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med 1997;6:43–49
Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary artery risk development in young adults. Arch Int Med 2000;160:1495–1500
Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. Br Med J (Clin Res Ed) 1987;295:297–299
Kawachi I, Colditz GA, Ascherio A, Rimm EB, Giovannucci E, Stampfer MJ, Willett WC. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89:1992–1997
Kawachi I, Sparrow D,Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994;90:2225–2229
Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and coronary death among women: psychological predictors from a 20-year follow-up of women in the Framingham study. Am J Epidemiol 1992;135:854–864
Kubzansky LD, Kawachi I. Going to the heart of the matter: do negative emotions cause coronary artery disease. J Psychosom Res 2000;48:323–337
Gallacher JEJ, Yamell JWG, Sweetman PM, Elwood PC, Stansfeld SA. Anger and incident heart disease in the Caerphilly Study. Psychosom Med 1999;61:446–453
Everson SA, Kaplan GA, Goldberg DE, Lakka TA, Sivenius J, Salonen JT. Anger expression and incident stroke: prospective evidence from the Kuopio ischemic heart disease study. Stroke 1999;30:523–528
Stone PH, Krantz DS, McMahon RP, Goldberg AD, Becker LC, Chaitman BR, Taylor HA, Cohen JD, Freedland KE, Bertolet BD, Coughlan C, Pepine CG, Kaufmann PG, Sheps DS. Relationship among mental stress-induced ischemia and ischemia during daily life and during exercise: the Psychological Investigations of Myocardial Ischemia (PIMI) Study. JAm Coll Cardiol 1999;33:1476–1484
Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman RE, Hanson MM, Frid DJ, McNulty S, Morris JJ, O’Connor CM, Blumenthal JA. Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996;275:1651–1656
Schoder H, Silverman DH, Karpman H, Phelps ME, Schelbert HR, Czermin J. Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. J Nucl Med 2000;41:11–16
Lampart R, Jain D, Burg MM, Batsford WP, McPherson CA. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverterdefibrillators. Circulation 2000;101:158–164
Hoffmann B, Ladwig KH, Schapperer J, Deisenhofer I, Marten-Mittag B, Danner R, Schmitt C. Psychoneurogenic factors as a cause of life-threatening arrhythmias. Nervenarzt 1999;70:830–835
Ahmad M, Bloomstein L, Roelke M, Bernstein AD, Parsonnet V. Patients’ attitudes toward defibrillator shocks. PACE 2000;23:934–938
Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg JS. Psychosocial outcome after ICD implantation: a current perspective. PACE 1998;21:1207–1215
Crow SJ, Collins J, Justic M, Goetz R, Adler S. Psychopathology following cardioverter-defibrillator implantation. Psychosomatics 1998;39:305–310
Peterson C, Seligman ME. Explanatory style and illness. J Pers 1987;55:237–265
Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996;334:413–419
Schnall PL, Scwartz JE, Landsbergis PA, Warren K, Pickering TG. A longitudinal study of job strain and ambulatory pressure: results of a three-year follow-up. Psychosom Med 1998;60:697–706
Pickering TG, Devereux RB, James GD, Gerin W, Landbergis P, Schnall PL, Schwartz JE. Environmental influences on blood pressure and the role of job strain. J Hypertens Suppl 1996;14: S179–S185
Cesana G, Ferrario M, Sega R, Milesi C, De Vito G, Mancia G, Zanchetti A. Job strain and ambulatory blood pressure levels in a population-based employed sample of men from northern Italy. Scand J Work Environ Health 1996;22:294–305
Stahl SM, Hauger RL. Stress: an overview of the literature with emphasis on job-related strain and intervention. Adv Ther 1994;11:110–119
Spence JD, Barnett PA, Linden W, Ramsden V, Taenzer P. Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ 1999; 160 (9 Suppl):546–550
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 1997;157:2413–2446
Ladwig K-H, Schoefinius A, Dammann G, Danner R, Gürtler R, Herrmann R. Long-acting psychotraumatic properties of a cardiac arrest experience. Am J Psychiatry 1999;156:912–919
Bremmer SM, McCauley KM, Axtell KA. A follow-up study of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs 1993;7:40–51
Dougherty CM. Longitudinal recovery following sudden cardiac arrest and internal cardioverter defibrillator implantation: survivors and their families. Am J Critical Care 1994;3:1445–154
May CD, Smith PR, Murdock CJ, Davis MJE. The impact of the implantable cardioverter-defibrillator on quality of life. PACE 1995;18:1411–1418
Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991;32:58–64
Carney JM, Mandle CL, Munro BH, Rankin S. Implantable cardioverter defibrillators: physical and psychological outcomes. Am J Crit Care 1997; 6:445–451
Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-life in patients receiving implantable cardioverter-defibrillators at or before age 40. PACE 1996;19 (part I): 1555–1559
Pacifico A, Wheelan KR, Nasir N, Jr., Wells PJ, Doyle TK, Johnson SA, Henry PD. Lopng-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral position. Circulation 1997;95:946–950
Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, Curtis AB, Conti JB. Assessing the psychological impact of the ICD: a national survey of implantable cardioverter-defibrillator health providers. PACE 2000;23:939–945
Keren R, Aarons D, Veltri EP. Anxiety and depression in patients with life-threatening ventricular arrhythmias: impact of the implantable cardioverter-defibrillator. PACE 1991;14 (part I):181–187
Schuster PM, Phillips S, Dillon DL, Tomich PL. The psychological and physiological experiences of patients with an implantable cardioverter-defibrillator. Rehabil Nurs 1998;23:30–37
Chevalier P, Verrier P, Kirkorian G, Touboul P. Cottraux J. Improved appraisal of the quality of life in patients with automatic implantable cardioverter defibrillator. Psychother Psychosom 1996;65:49–56
Burgess ES, Quigley JF, Moran G, Sutton FJ, Goodman M. Predictors of psychosocial adjustment in patients with implantable cardioverter defibrillators. PACE 1997;20:1790–1795
Dunbar SB, Kimble LP, Jenkins LS, Hawthorne M, Dudley W, Slemmons M, Langberg JJ. Association of mood disturbance and arrhythmia events in patients after cardioverter defibrillator implantation. Depress Anxiety 1999;9:163–168
Sneed NV, Finch N. Experiences of patients and significant others with automatic implantable cardioverter defibrillators after hospital discharge. Progr Cardiovasc Nurs 1992;7:20–24
Pycha C, Calabrese JR, Gulledge AD, Maloney JD. Patient and spouse acceptance and adaptation to implantable cardioverter defibrillators. Cleve Clinic J Med 1990;57:441–444
Cooper DK, Luceri RM, Thurer RJ, Myerburg RJ. The impact of the automatic cardioverter defibrillator on quality of life. Clin Progr Electrophysiol Pacing 1986;4:306–309
Lüderitz B, Jung W, Deister, Manz M. Quality of life in multiprogrammable cardioverter-defibrillator recipients. In Interventional Electrophysiology—A Textbook. Saksena S, Luderitz B, Eds. Futura Publishing Company, Inc, Amonk, NY,1996:305–313
Herrmann C, von zur Mühen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska B-D. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. PACE 1997;20 (part I):95–103
Hegel MT, Griegel LE, Black C, Goulden L. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal study. Int J Psychiatry in Med 1997;27:57–69
Baker B, Kazarian SS, Dorian P, Lanphier C. Psychiatric asssessment of patients with life-threatening cardiac arrhythmias. Int J Psychiatry Med 1993;23:43–53
Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung 1995;24:281–291
Vlay SC, Olson LC, Frichione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. PACE 1989;12:366–373
Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M. Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators. Heart 1997;78:581–583
Godeman F, Ahrens B, Behrens S, Bethold R, Gandor C, Lampe F, Linden M. Classic conditioning and dysfunctional cognitions in patients with panic disorders and agoraphobia with an implantable cardioverter/defibrillator. Psychosom Med 2001;63:231–238
Pacifico A, Ferlic LL, Cedillo-Salazar FR, Nasir N, Jr, Doyle TK, Henry PD. Shocks as predictors of survival in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 1999;34:204–210
Roman DD, Kubo SH, Ormaza S, Francis GS, Bank AJ, Shumway SJ. Memory improvement following cardiac transplantation. J Clin Exp Neuropsychol 1997;19:692–697
Sauvé MJ. Long-term physical functioning and psychosocial adjustment in survivors of sudden cardiac death. Heart Lung 1995;24:133–144
De Vries JW, Bakker PFA, Visser GH, Diephuis JC, van Huffelen AC. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillationj threshold testing. Anesth Analg 1998;87:16–20
Murkin JM, Baird DL, Martzke JS, Yee R. Cognitive dysfunction after ventricular fibrillation during implantable cardioverter/defibrillator procedures is related to duration of the reperfusion interval. Anesth Analg 1997;84:1186–1192
Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN. Prevention of implantable defibrillator shocks by treatment with sotalol. N Engl J Med 1999;340:1855–1862
Seines OA, Goldsborough MA, Borowicz LM, McKhann GM. Neurobehavioural sequelae of cardiopulmonary bypass. Lancet 1999;353:1601–1606
Wijesinghe LD, Gamage L, Berridge DC, Scott DJ. Measuring serum cholesterol: do vascular surgeons know what they are doing? Ann R Coll Surg Engl 1999;81:32–36
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and the CAST investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 1991;324:781–788
Glassman AH. Cardiovascular effects of antidepressant drugs: updated. J Clin Psychiatry 1998;59 (suppl 15):13–18
Roose SP, Spatz E. Treatment of depression in patients with heart disease. J Clin Psychiatry 1999;60 (suppl 20):30–37
Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson C, Bigger JT, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287–291
Palatini P. Heart rate as a risk factor for atherosclerosis and cardiovascular mortality: the effect of antihypertensive drugs. Drugs 1999;57:713–724
Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc 2000;75:790–795
Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 2000;85:11–28
Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev 2000;(2):Cd001851
Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord 2000;60:33–41
Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000;58:19–36
Hirschfeld RM. Efficacy of SSRIs and newer antidepressants in severe depression: comparisons with TCAs. J Clin Psychiatry 1999;60:326–335
Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety 1997; 6:10–18
Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. Clin Psycopharmacol 1999;19:67–85
Oberndorfer S, Saletu-Zyhlarz G, Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology 2000;42:6981
Fava M. Weight gain and antidepressants. J Clin P_sychiatry 2000;61 (suppl 11):37–41
Harvey BH, Bouwer CD. Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors. Clin Neuropharmacol 2000;23:90–97
Schatzberg AF. New indications for antidepressants. J Clin Psychiatry 2000;61 (suppl 11):9–17
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillation Implantation Trial (MADIT) Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med 1996;335:1933–1940
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigstors. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New Engl J Med 1997;337:1576–1583
Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O’Toole MF, Tang A, Fisher JD. N Engl J Med 2000;342:1937–1945. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial (MUSTY) Investigators.
Berkman L, Jaffee A. ENRICHD — Treatment of depression and social isolation post MI. Presented at the American Heart Association Scientific Sessions, November 11–14, 2001, Anaheim.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Henry, P.D., Pacifico, A. (2002). Anxiety and Depression. In: Pacifico, A., et al. Implantable Defibrillator Therapy: A Clinical Guide. Developments in Cardiovascular Medicine, vol 244. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1055-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1055-0_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5372-0
Online ISBN: 978-1-4615-1055-0
eBook Packages: Springer Book Archive